A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis in Heart and Kidney Transplant Recipients in Japan

被引:21
|
作者
Owada, Yohei [1 ]
Oshiro, Yukio [1 ]
Inagaki, Yuki [1 ]
Harada, Hiroshi [2 ]
Fujiyama, Nobuhiro [3 ]
Kawagishi, Naoki [4 ]
Yagisawa, Takashi [5 ]
Usui, Joichi [6 ]
Akutsu, Naotake [7 ]
Itabashi, Yoshihiro [8 ]
Saito, Kazuhide [9 ]
Watarai, Yoshihiko [10 ]
Ichimaru, Naotsugu [11 ]
Imamura, Ryoichi [12 ]
Kyakuno, Miyaji [13 ]
Ide, Kentaro [14 ]
Shibuya, Yuichi [15 ]
Okabe, Yasuhiro [16 ]
Ono, Minoru [17 ]
Sasaki, Konosuke [18 ]
Shiose, Akira [19 ]
Yamagishi, Kazumasa [20 ]
Ohnishi, Hiroshi [21 ]
Nagashima, Shigeo [21 ]
Takahashi, Masaharu [21 ]
Yuzawa, Kenji [22 ]
Okamoto, Hiroaki [21 ]
Ohkohchi, Nobuhiro [1 ]
机构
[1] Univ Tsukuba, Fac Med, Dept Gastrointestinal & Hepatobiliary Pancreat Su, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan
[2] Sapporo City Gen Hosp, Kidney Transplant Surg, Chuou Ku, Sapporo, Hokkaido, Japan
[3] Akita Univ Hosp, Ctr Kidney Dis & Transplantat, Akita, Japan
[4] JCHO Sendai Hosp, Dept Surg, Aoba Ku, Sendai, Miyagi, Japan
[5] Jichi Med Univ Hosp, Dept Renal Surg & Transplantat, Shimotsuke, Tochigi, Japan
[6] Univ Tsukuba, Fac Med, Dept Nephrol, Tsukuba, Ibaraki, Japan
[7] Chiba East Natl Hosp, Dept Surg, Chiba, Chiba, Japan
[8] Toho Univ, Fac Med, Dept Nephrol, Ota Ku, Tokyo, Japan
[9] Niigata Univ, Grad Sch Med & Dent Sci, Dept Regenerat & Transplant Med, Div Urol,Chuo Ku, Niigata, Japan
[10] Nagoya Daini Red Cross Hosp, Dept Transplant Surg, Showa Ku, Nagoya, Aichi, Japan
[11] Osaka Univ, Dept Adv Technol Transplantat, Grad Sch Med, Suita, Osaka, Japan
[12] Osaka Univ, Dept Urol, Grad Sch Med, Suita, Osaka, Japan
[13] Takatsuki Gen Hosp, Dept Renal Transplantat, Takatsuki, Osaka, Japan
[14] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Minami Ku, Hiroshima, Japan
[15] Kochi Hlth Sci Ctr, Dept Gastroenterol Surg, Kochi, Kochi, Japan
[16] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Higashi Ku, Fukuoka, Japan
[17] Univ Tokyo, Grad Sch Med, Dept Cardiac Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan
[18] Tohoku Univ, Div Cardiovasc Surg, Grad Sch Med, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi, Japan
[19] Kyushu Univ, Dept Cardiovasc Surg, Fac Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Japan
[20] Univ Tsukuba, Fac Med, Dept Publ Hlth Med, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan
[21] Jichi Med Univ, Dept Infect & Immun, Div Virol, Sch Med, 3311-1 Yakushiji, Shimotsuke, Tochigi, Japan
[22] Natl Hosp Org Mito Med Ctr, Dept Transplantat Surg, 280 Sakuranosato, Ibaraki, Ibaraki, Japan
关键词
LIVER; STRAINS; ANTIBODIES; FEATURES;
D O I
10.1097/TP.0000000000002801
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Recently, chronic hepatitis E has been reported in solid organ transplant (SOT) recipients in European countries. Previously, we clarified the prevalence of hepatitis E virus (HEV) infection in Japanese liver transplant recipients and identified 2 chronic hepatitis E patients infected by blood transfusion. However, the rate of HEV infection in recipients of SOTs other than liver in Japan remains unclear, so we conducted a nationwide survey to clarify the prevalence of chronic HEV infection in Japanese heart and kidney transplant recipients. Methods. A total of 99 heart and 2526 kidney transplant recipients in 17 hospitals in Japan were examined for the presence of the IgG class of anti-HEV antibodies as well as for serum HEV RNA. Results. The prevalence of anti-HEV IgG among heart and kidney transplant recipients was 7.07% (7/99) and 4.08% (103/2526), respectively. One heart transplant patient (1.01%) and 11 kidney transplant patients (0.44%) were found to be positive for HEV RNA. The HEV isolates from all viremic patients were typed as genotype 3. Four patients developed chronic hepatitis E after transplantation. Three patients were treated with ribavirin; their liver enzymes normalized, and HEV RNA became negative immediately. Sustained virologic response was achieved in all cases. Conclusions. This is the first nationwide survey of HEV infection in Japanese heart and kidney transplant recipients. The prevalence of anti-HEV IgG and HEV RNA in heart and kidney transplant recipients in Japan was lower than that in European countries. Of note, 42% of viremic transplant patients developed chronic hepatitis.
引用
收藏
页码:437 / 444
页数:8
相关论文
共 50 条
  • [11] Chronic Hepatitis E in Heart Transplant Recipients
    Pischke, S.
    Stiefel, P.
    Franz, B.
    Bremer, B.
    Suneetha, P. V.
    Heim, A.
    Ganzenmueller, T.
    Schlue, J.
    Horn-Wichmann, R.
    Raupach, R.
    Darnedde, M.
    Scheibner, Y.
    Taubert, R.
    Haverich, A.
    Manns, M. P.
    Wedemeyer, H.
    Bara, C. L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (11) : 3128 - 3133
  • [12] Hepatitis E virus infection in heart transplant recipients, Southeastern France
    Luciani, Lea
    Deharo, Pierre
    Aherfi, Sarah
    Chalvignac, Virginie
    Borentain, Patrick
    Colson, Philippe
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (01) : 108 - 111
  • [13] Hepatitis G virus infection in chronic dialysis patients and kidney transplant recipients
    Fabrizi, F
    Lunghi, G
    Bacchini, G
    Corti, M
    Guarnori, I
    Raffaele, L
    Erba, G
    Pagano, A
    Locatelli, F
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (08) : 1645 - 1651
  • [14] Hepatitis E Virus Infection in Lung Transplant Recipients
    Ambrocio, G.
    Aguilar Perez, M.
    Laporta, R.
    Lazaro, M.
    Avellon, A.
    Aran-Toha, G.
    Martos Gisbert, N.
    Ussetti Gil, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S77 - S78
  • [15] Chronic hepatitis E infection in lung transplant recipients
    Riezebos-Brilman, Annelies
    Puchhammer-Stockl, Elisabeth
    van der Weide, Hinke Y.
    Haagsma, Elizabeth B.
    Jaksch, Peter
    Bejvl, Isabella
    Niesters, Hubert G.
    Verschuuren, Erik A. M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (03): : 341 - 346
  • [16] Course and treatment of chronic hepatitis E virus infection in lung transplant recipients
    Pischke, S.
    Greer, M.
    Hardtke, S.
    Bremer, B.
    Gisa, A.
    Lehmann, P.
    Haverich, A.
    Welte, T.
    Manns, M. P.
    Wedemeyer, H.
    Gottlieb, J.
    TRANSPLANT INFECTIOUS DISEASE, 2014, 16 (02) : 333 - 339
  • [17] Prevalence and characteristics of hepatitis E virus infection in kidney transplant recipients: A single-center experience in Japan
    Nanmoku, Koji
    Owada, Yohei
    Oshiro, Yukio
    Kurosawa, Akira
    Kubo, Taro
    Shinzato, Takahiro
    Shimizu, Toshihiro
    Kimura, Takaaki
    Sakuma, Yasunaru
    Ishikawa, Nobuo
    Ohkohchi, Nobuhiro
    Okamoto, Hiroaki
    Yagisawa, Takashi
    TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (02)
  • [18] Hepatitis E Virus Infection as a Cause of Graft Hepatitis in Liver Transplant Recipients
    Pischke, Sven
    Suneetha, Pothakamuri V.
    Baechlein, Christine
    Barg-Hock, Hannelore
    Heim, Albert
    Kamar, Nassim
    Schlue, Jerome
    Strassburg, Christian P.
    Lehner, Frank
    Raupach, Regina
    Bremer, Birgit
    Magerstedt, Peter
    Cornberg, Markus
    Seehusen, Frauke
    Baumgaertner, Wolfgang
    Klempnauer, Juergen
    Izopet, Jacques
    Manns, Michael P.
    Grummer, B.
    Wedemeyer, Heiner
    LIVER TRANSPLANTATION, 2010, 16 (01) : 74 - 82
  • [19] Relevance of Tacrolimus Trough Concentration and Hepatitis E virus Genetic Changes in Kidney Transplant Recipients With Chronic Hepatitis E
    Leon-Janampa, Nancy
    Boennec, Natacha
    Le Tilly, Olivier
    Ereh, Simon
    Herbet, Gabriel
    Moreau, Alain
    Gatault, Philippe
    Longuet, Helene
    Barbet, Christelle
    Buchler, Mathias
    Baron, Christophe
    Gaudy-Graffin, Catherine
    Brand, Denys
    Marlet, Julien
    KIDNEY INTERNATIONAL REPORTS, 2024, 9 (05): : 1333 - 1342
  • [20] Prevalence of hepatitis G virus infection in kidney transplant recipients
    Dussol, B
    Charrel, R
    DeLamballerie, X
    Berthezene, P
    Brunet, P
    DeMicco, P
    Raoult, D
    Berland, Y
    TRANSPLANTATION, 1997, 64 (03) : 537 - 539